Cancer Clinical Trials:

Medicare Reimbursement Denials

HEHS-98-15R: Published: Oct 14, 1997. Publicly Released: Nov 14, 1997.

Additional Materials:

Contact:

Bernice Steinhardt
(202) 512-3000
contact@gao.gov

 

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

Pursuant to a congressional request, GAO determined the potential effect of the proposed Medical Cancer Clinical Trial Coverage Act by estimating the current rate at which Medicare carriers deny reimbursements for routine patient care costs when beneficiaries are enrolled in cancer clinical trials.

GAO noted that: (1) its survey method did not allow it to give a precise national estimate of the rate at which reimbursement is denied for Medicare beneficiaries enrolled in cancer clinical trials; and (2) the results suggest that denial of reimbursement is relatively rare, given the populations and time period of its review.

Mar 1, 2021

Feb 24, 2021

Feb 17, 2021

Feb 11, 2021

Feb 5, 2021

Jan 28, 2021

Jan 21, 2021

Looking for more? Browse all our products here